Aripiprazole augmentation of tranylcypromine in treatment-resistant major depression.
Goforth
Harold W
HW
Carroll
Brendan T
BT
D000328:Adult; D000928:Antidepressive Agents / Q000627:therapeutic use; D014150:Antipsychotic Agents / Q000627:therapeutic use; D000068180:Aripiprazole; D003865:Major Depressive Disorder / Q000188:drug therapy*; D004351:Drug Resistance / Q000187:drug effects; D004357:Drug Synergism; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D008875:Middle Aged; D008996:Monoamine Oxidase Inhibitors / Q000627:therapeutic use; D010879:Piperazines / Q000627:therapeutic use*; D015363:Quinolones / Q000627:therapeutic use*; D014191:Tranylcypromine / Q000627:therapeutic use*; D016896:Treatment Outcome
D000928:Antidepressive Agents; D014150:Antipsychotic Agents; D008996:Monoamine Oxidase Inhibitors; D010879:Piperazines; D015363:Quinolones; D014191:Tranylcypromine; D000068180:Aripiprazole